The regulatory role of immune response in oral Lichen planus with mental disorders

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000037988

Enrollment

Unknown

Registered

2020-09-08

Start date

2020-09-07

Completion date

Unknown

Last updated

2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral lichen planus

Interventions

Normal control group:Nil

Erosion type:Nil

Non-erosive type:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with oral lichen planus diagnosed clinically and histopathologically; 2. Male or female patients aged 18-65 years; 3. Patients without cognitive impairment and mental illness can understand the questionnaire content and answer questions normally; 4. Patients who are willing to participate in the trial and fill in the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Patients with serious heart, lung, liver, kidney and other systemic diseases, and patients with tumors.

Design outcomes

Primary

Measure	Time frame
Curative effect evaluation;	—

Countries

China

Contacts

Public ContactZhihui Zhang

Peking University Third Hospital

wisdomzhangzhihui@163.com+86 18810534611

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026